1887

Abstract

Purpose. To investigate linezolid-resistance mechanisms in linezolid-nonsusceptible enterococci (LNSE) isolated from a tertiary hospital in Korea.

Methodology. Enterococcal isolates exhibiting linezolid MICs ≥4 mg l that were isolated between December 2011 and May 2016 were investigated by PCR and sequencing for mutations in 23S rRNA or ribosomal proteins (L3, L4 and L22) and for the presence of cfr, cfr(B) and optrA genes.

Results/Key findings. Among 135 LNSE (87 Enterococcus faecium and 48 Enterococcus faecalis isolates), 39.1 % (34/87) of E. faecium and 18.8 % (9/48) of E. faecalis isolates were linezolid-resistant. The optrA carriage was the dominant mechanism in E. faecalis: 13 isolates, including 10 E. faecalis [70 % (7/10) linezolid-resistant and 30 % (3/10) linezolid-intermediate] and three E. faecium [33.3 % (1/3) linezolid-resistant and 66.7 % (2/3) linezolid-intermediate], contained the optrA gene. G2576T mutations in the 23S rRNA gene were detected only in E. faecium [14 isolates; 71.4 % (10/14) linezolid-resistant and 28.6 % (4/14) linezolid-intermediate]. One linezolid-intermediate E. faecium harboured a L22 protein alteration (Ser77Thr). No isolates contained cfr or cfr(B) genes and any L3 or L4 protein alterations. No genetic mechanism of resistance was identified for 67.6 % (23/34) of linezolid-resistant E. faecium.

Conclusion. A low rate of 23S rRNA mutations and the absence of known linezolid-resistance mechanisms in the majority of E. faecium isolates suggest regional differences in the mechanisms of linezolid resistance and the possibility of additional mechanisms.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000637
2017-11-07
2019-09-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/12/1730.html?itemId=/content/journal/jmm/10.1099/jmm.0.000637&mimeType=html&fmt=ahah

References

  1. Mendes RE, Deshpande LM, Jones RN. Linezolid update: stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms. Drug Resist Updat 2014;17:1–12 [CrossRef][PubMed]
    [Google Scholar]
  2. Flamm RK, Mendes RE, Hogan PA, Streit JM, Ross JE et al. Linezolid surveillance results for the United States (LEADER surveillance program 2014). Antimicrob Agents Chemother 2016;60:2273–2280 [CrossRef][PubMed]
    [Google Scholar]
  3. Mendes RE, Hogan PA, Jones RN, Sader HS, Flamm RK. Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates. J Antimicrob Chemother 2016;71:1860–1865 [CrossRef][PubMed]
    [Google Scholar]
  4. Mendes RE, Hogan PA, Streit JM, Jones RN, Flamm RK. Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program: report of linezolid activity over 9 years (2004–12). J Antimicrob Chemother 2014;69:1582–1588 [CrossRef][PubMed]
    [Google Scholar]
  5. Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol 2005;57:1064–1073 [CrossRef][PubMed]
    [Google Scholar]
  6. Deshpande LM, Ashcraft DS, Kahn HP, Pankey G, Jones RN et al. Detection of a new cfr-like gene, cfr(B), in Enterococcus faecium isolates recovered from human specimens in the United States as part of the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 2015;59:6256–6261 [CrossRef][PubMed]
    [Google Scholar]
  7. Wang Y, Lv Y, Cai J, Schwarz S, Cui L et al. A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin. J Antimicrob Chemother 2015;70:2182–2190 [CrossRef][PubMed]
    [Google Scholar]
  8. Cai J, Wang Y, Schwarz S, Lv H, Li Y et al. Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010–2014. Clin Microbiol Infect 2015;21:1095.e1–1095.e4 [CrossRef]
    [Google Scholar]
  9. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 10th ed. M07–A10 Wayne, PA: CLSI; 2015
    [Google Scholar]
  10. CLSI Performance Standards for Antimicrobial Susceptibility Testing twenty-sixth informational supplement. M100–S26 Wayne, PA: CLSI; 2016
    [Google Scholar]
  11. Prystowsky J, Siddiqui F, Chosay J, Shinabarger DL, Millichap J et al. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob Agents Chemother 2001;45:2154–2156 [CrossRef][PubMed]
    [Google Scholar]
  12. Wang L, He Y, Xia Y, Wang H, Liang S. Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China. Infect Genet Evol 2014;26:14–19 [CrossRef][PubMed]
    [Google Scholar]
  13. Arias CA, Vallejo M, Reyes J, Panesso D, Moreno J et al. Clinical and microbiological aspects of linezolid resistance mediated by the cfr gene encoding a 23S rRNA methyltransferase. J Clin Microbiol 2008;46:892–896 [CrossRef][PubMed]
    [Google Scholar]
  14. Brenciani A, Morroni G, Vincenzi C, Manso E, Mingoia M et al. Detection in Italy of two clinical Enterococcus faecium isolates carrying both the oxazolidinone and phenicol resistance gene optrA and a silent multiresistance gene cfr. J Antimicrob Chemother 2016;71:1118–1119 [CrossRef][PubMed]
    [Google Scholar]
  15. Alonso M, Marín M, Iglesias C, Cercenado E, Bouza E et al. Rapid identification of linezolid resistance in Enterococcus spp. based on high-resolution melting analysis. J Microbiol Methods 2014;98:41–43 [CrossRef][PubMed]
    [Google Scholar]
  16. Bae HG, Sung H, Kim MN, Lee EJ, Koo Lee S. First report of a linezolid- and vancomycin-resistant Enterococcus faecium strain in Korea. Scand J Infect Dis 2006;38:383–386 [CrossRef][PubMed]
    [Google Scholar]
  17. Patel SN, Memari N, Shahinas D, Toye B, Jamieson FB et al. Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada. Diagn Microbiol Infect Dis 2013;77:350–353 [CrossRef][PubMed]
    [Google Scholar]
  18. Klare I, Fleige C, Geringer U, Thürmer A, Bender J et al. Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients. J Glob Antimicrob Resist 2015;3:128–131 [CrossRef][PubMed]
    [Google Scholar]
  19. Gawryszewska I, Żabicka D, Hryniewicz W, Sadowy E. Linezolid-resistant enterococci in Polish hospitals: species, clonality and determinants of linezolid resistance. Eur J Clin Microbiol Infect Dis 2017;36:1279–1286 [CrossRef][PubMed]
    [Google Scholar]
  20. Diaz L, Kiratisin P, Mendes RE, Panesso D, Singh KV et al. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother 2012;56:3917–3922 [CrossRef][PubMed]
    [Google Scholar]
  21. Cai J, Wang Y, Schwarz S, Zhang G, Chen S et al. High detection rate of the oxazolidinone resistance gene optrA in Enterococcus faecalis isolated from a Chinese anorectal surgery ward. Int J Antimicrob Agents 2016;48:757–759 [CrossRef][PubMed]
    [Google Scholar]
  22. Huang J, Chen L, Wu Z, Wang L. Retrospective analysis of genome sequences revealed the wide dissemination of optrA in Gram-positive bacteria. J Antimicrob Chemother 2017;72:614–616 [CrossRef][PubMed]
    [Google Scholar]
  23. Cui L, Wang Y, Lv Y, Wang S, Song Y et al. Nationwide surveillance of novel oxazolidinone resistance gene optrA in Enterococcus Isolates in China from 2004 to 2014. Antimicrob Agents Chemother 2016;60:7490–7493 [CrossRef][PubMed]
    [Google Scholar]
  24. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 2000;289:905–920 [CrossRef][PubMed]
    [Google Scholar]
  25. Shore AC, Lazaris A, Kinnevey PM, Brennan OM, Brennan GI et al. First report of cfr-carrying plasmids in the pandemic sequence type 22 methicillin-resistant Staphylococcus aureus staphylococcal cassette chromosome mec type IV Clone. Antimicrob Agents Chemother 2016;60:3007–3015 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000637
Loading
/content/journal/jmm/10.1099/jmm.0.000637
Loading

Data & Media loading...

Supplementary File 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error